(Q35535485)

8 August 2017

title

The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. (English)

1 reference

8 August 2017

1 reference

7

Willem M de Vos

1 reference

8 August 2017

Noortje G Rossen

1

1 reference

8 August 2017

Susana Fuentes

2

1 reference

8 August 2017

Kirsten Boonstra

3

1 reference

8 August 2017

Geert R D'Haens

4

1 reference

8 August 2017

Hans G Heilig

5

1 reference

8 August 2017

Erwin G Zoetendal

6

1 reference

8 August 2017

Cyriel Y Ponsioen

8

1 reference

8 August 2017

publication date

28 December 2014

1 reference

Journal of Crohn's and Colitis

8 August 2017

published in

1 reference

8 August 2017

volume

9

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

342-348

1 reference

Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Phylogenetic analysis of dysbiosis in ulcerative colitis during remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Altered profile of human gut microbiome is associated with cirrhosis and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Long-term monitoring of the human intestinal microbiota composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Gut microbiomes of Malawian twin pairs discordant for kwashiorkor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Tipping elements in the human intestinal ecosystem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU023

21 January 2018

Identifiers

DOI

10.1093/ECCO-JCC/JJU023

1 reference

8 August 2017

1 reference